Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.
about
Multidrug resistance proteins (MRPs/ABCCs) in cancer chemotherapy and genetic diseasesThe biological significance of brain barrier mechanisms: help or hindrance in drug delivery to the central nervous system?The Nrf2-ARE pathway: a valuable therapeutic target for the treatment of neurodegenerative diseasesCell-culture models of the blood-brain barrierBlood-brain barrier integrity and glial support: mechanisms that can be targeted for novel therapeutic approaches in strokeTransporters at CNS barrier sites: obstacles or opportunities for drug delivery?Blood brain barrier: a challenge for effectual therapy of brain tumorsAssociation study of genetic polymorphism in ABCC4 with cyclophosphamide-induced adverse drug reactions in breast cancer patientsEfflux protein expression in human stem cell-derived retinal pigment epithelial cellsOntogeny of ABC and SLC transporters in the microvessels of developing rat brainNrf2 signaling increases expression of ATP-binding cassette subfamily C mRNA transcripts at the blood–brain barrier following hypoxia-reoxygenation stressConstitutive activation of Galphas within forebrain neurons causes deficits in sensorimotor gating because of PKA-dependent decreases in cAMP.A guide to the metabolic pathways and function of metabolites observed in human brain 1H magnetic resonance spectra.MRP3: a molecular target for human glioblastoma multiforme immunotherapy.Three novel ABCC5 splice variants in human retina and their role as regulators of ABCC5 gene expressionPolymorphism in multidrug resistance-associated protein gene 3 is associated with outcomes in childhood acute lymphoblastic leukemia.Role of Transporters in Central Nervous System Drug Delivery and Blood-Brain Barrier Protection: Relevance to Treatment of StrokeABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNSXenobiotic, bile acid, and cholesterol transporters: function and regulation.Mice lacking Mrp1 have reduced testicular steroid hormone levels and alterations in steroid biosynthetic enzymesDrug-Resistant Epilepsy: Multiple Hypotheses, Few AnswersRecombinant single-chain variable fragment antibodies against extracellular epitopes of human multidrug resistance protein MRP3 for targeting malignant gliomas.Drug delivery across the blood-brain barrier: why is it difficult? how to measure and improve it?Expression and function of multidrug resistance transporters at the blood-brain barriers.Effluxing ABC transporters in human corneal epithelium.Analysis of the mdr-1 gene in patients co-infected with Onchocerca volvulus and Loa loa who experienced a post-ivermectin serious adverse event.Mechanisms of membrane transport of folates into cells and across epithelia.The blood-brain barrier in health and disease.Free radical mediated oxidative stress and toxic side effects in brain induced by the anti cancer drug adriamycin: insight into chemobrain.Molecular biology of the blood-brain and the blood-cerebrospinal fluid barriers: similarities and differencesThe absence of mrp4 has no effect on the recruitment of neutrophils and eosinophils into the lung after LPS, cigarette smoke or allergen challenge.Vascular and extravascular distribution of the ATP-binding cassette transporters ABCB1 and ABCC1 in aged human brain and pituitary.Drug resistance in cortical and hippocampal slices from resected tissue of epilepsy patients: no significant impact of p-glycoprotein and multidrug resistance-associated proteinsABC transporter-driven pharmacoresistance in Amyotrophic Lateral Sclerosis.Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.Midbrain dopamine neurons in Parkinson's disease exhibit a dysregulated miRNA and target-gene networkTargeting blood-brain barrier changes during inflammatory pain: an opportunity for optimizing CNS drug delivery.ABC Transporters and the Alzheimer's Disease Enigma.Hypoxic Stress Induced by Hydralazine Leads to a Loss of Blood-Brain Barrier Integrity and an Increase in Efflux Transporter ActivityLoss of multidrug resistance-associated protein 1 potentiates chronic doxorubicin-induced cardiac dysfunction in mice.
P2860
Q24601963-B2C42A84-4FEE-4E50-BFCC-A8483D2D4B0CQ26753140-F76DBF57-240C-4360-8965-84FF2EE01C18Q26822972-80E12B0B-7208-455E-805F-BC1B2EBEE455Q26827093-BE957AF4-2BAF-41D5-8DB4-FFD13AF10A73Q26864317-56ABAFD8-88B6-4FD7-88D9-B0E6371FBED3Q27690256-FDD98FAD-A167-419D-A545-5B64AEE8AA03Q28081947-BA024217-8550-47B7-8E83-647E81815CAFQ28255901-AF7A667D-B3F4-4695-ACC4-F499BE222CC3Q28478917-4275B19A-7EDF-42C3-8A90-68BA24DD1095Q28566257-4843349A-9B20-4B03-8976-FEB356C62395Q29247906-D0D3B3A7-DA0A-49AA-905E-CC1DE26DD88BQ30469594-28D3E920-2ED0-4367-80E8-34F699F6998FQ30698264-046DFE9E-254F-4BA1-8CCB-EC2130405195Q30988770-C10863D0-CFEA-47D7-90ED-DF46A4D4AAC3Q33285545-BE937B14-96BE-4CB2-8EDA-4AD6800E6061Q33395469-EB2BEA7C-E01A-4FBD-A6F9-C23BB203CD59Q33565967-3A9ECFF2-B706-4E3E-AEF2-30B837FA22A0Q33651875-AFEB1BDE-CF88-45A9-BC59-C9FCD1BE2065Q33714593-21718E6C-25D4-49C2-97F1-F4B1EC399823Q33823515-8FC18213-4034-4A44-9477-DDD5B78A6285Q33875271-CD6D7A78-1CE7-4103-A103-9C43B744F3B5Q33886564-227C0103-732C-4A57-A14C-AA387ADA0E36Q33995372-DADDDA3A-3D8F-4A19-BFD3-3CAB28D873FFQ33998841-7FDF3441-FA88-4499-98C8-75AEF0BB4209Q34003651-F06F4C3E-EB60-49A8-B755-D2CC6A0F9694Q34030191-E5916BF5-B3B9-40B4-84D0-DCA9899305DBQ34184787-ABF5ECCC-FB96-4BE2-B312-DF0B0CC315F4Q34320420-D1B5BF52-8A3A-4BE7-ABFE-AB6A5348F8ACQ34468934-05C002ED-14F7-4AA4-98C5-B3205F4EA1AFQ34608061-B15C8902-4451-4877-80A7-50183FD93AE1Q34684137-95CB9603-4D8F-4862-AB1A-95D1FD788482Q35027962-3C90C534-98C4-4664-8988-CBB7B9D87A91Q35094603-BB60491A-3F5D-447F-8471-7F45C8221D97Q35132580-872CF782-A84F-4F8B-8FD5-41D9EDB25314Q35179525-FAA7E520-A4F6-45B7-9823-645DB7C508DFQ35654904-0F2EA615-2D47-4158-A328-8B2C44515530Q35855634-1ECB1EB8-4D15-4B0D-B310-302660F40C1AQ36005085-83B4DE04-6143-4019-928F-7D784590529DQ36060256-3F6FA307-02BA-473C-81D5-816DFC29B0B1Q36186168-2B1EADFB-7DD9-4924-A152-445CD617DAE0
P2860
Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Expression and immunolocalizat ...... (ABCC1-ABCC6), in human brain.
@ast
Expression and immunolocalizat ...... (ABCC1-ABCC6), in human brain.
@en
type
label
Expression and immunolocalizat ...... (ABCC1-ABCC6), in human brain.
@ast
Expression and immunolocalizat ...... (ABCC1-ABCC6), in human brain.
@en
prefLabel
Expression and immunolocalizat ...... (ABCC1-ABCC6), in human brain.
@ast
Expression and immunolocalizat ...... (ABCC1-ABCC6), in human brain.
@en
P2093
P1433
P1476
Expression and immunolocalizat ...... (ABCC1-ABCC6), in human brain.
@en
P2093
Herold-Mende C
Jedlitschky G
Schmitt HP
Steiner HH
P304
P356
10.1016/J.NEUROSCIENCE.2004.07.051
P407
P577
2004-01-01T00:00:00Z